Cite
HARVARD Citation
Engstrøm, T. et al. (2018). Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trial. Heart. 104 (19), pp. 1593-1599. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Engstrøm, T. et al. (2018). Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trial. Heart. 104 (19), pp. 1593-1599. [Online].